The Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta and Emory University School of Medicine provides advanced clinical care, innovative treatment and research options for children and young adults. We are one of the largest pediatric cancer, hematology, blood and marrow transplant (BMT) programs in the country. We are grateful for the collaborative relationships we have with other pediatric hematologists and oncologists nationwide.
2024
- In 2024, our faculty published more than 292 peer-reviewed publications highlighting innovative research findings and discoveries with 133 first or senior author papers.
- Overall awards for Aflac-associated researchers totaled nearly $32 million
- Highlights included:
- Continued IDIQ Contract funding for RADx - $5.5 million received in FY24 (Wilbur Lam)
- $800k Investment to become a Sickle Cell Transplant Research and Advocacy Alliance (STAR) Coordinating Center (Beth Stenger)
- R50 Award to establish an adolescent-young adult lymphoma program (Sharon Castellino)
2023
- In 2023, our faculty published more than 291 peer-reviewed publications highlighting innovative research findings and discoveries with 150 first or senior author papers.
- Overall awards for Aflac-associated researchers totaled nearly $110 million
- Highlights included:
- IDIQ Contract from the NIH to serve as the primary diagnostic test validation center - $49.8 million received in FY23 (Wilbur Lam)
- CURE Childhood Cancer $1.5 million grant to support Aflac's Precision Medicine Program (Sharon Castellino, Kelly Goldsmith, Tobey MacDonald, Chris Porter, and Ryan Summers)
- Katz Foundation $5 million grant to support Sickle Cell Disease quality initiatives (Beatrice Gee)
